U.S. Infrastructure Stock News

NYSE:F
NYSE:FAuto

How Unifor’s 2026 Talks and IR Shake-Up Will Impact Ford Motor (F) Investors

Ford Motor Company recently saw several developments, including Unifor’s decision to open the 2026 Detroit Three auto talks with Ford and the appointment of Maria Ricciardone as chief investor relations officer following strong first-quarter 2026 financial results. Together, the upcoming Canadian labor negotiations and leadership change in investor relations sharpen attention on Ford’s cost base, manufacturing stability, and communication of its Ford+ transformation plan. We’ll now examine...
NYSE:SEM
NYSE:SEMHealthcare

Is It Time To Reassess Select Medical Holdings (SEM) After Recent 2026 Guidance Update?

If you are wondering whether Select Medical Holdings at US$16.45 is still reasonably priced or already stretched, the valuation story is where things start to get interesting. The stock has been relatively steady in the short term, with returns of 0.1% over the last week and 0.5% over the last month, while the 11.0% year to date and 11.1% one year returns sit alongside a 16.0% three year return and a decline of 11.6% over five years. Recent coverage has focused less on short term headlines...
NasdaqGS:GSAT
NasdaqGS:GSATTelecom

Assessing Globalstar (GSAT) Valuation After Falcon 9 Launch Plans And Latest Earnings

Why Globalstar’s latest launch plan and earnings matter for the stock Globalstar (GSAT) is back in focus after confirming a May 17 Falcon 9 launch to replenish its satellite constellation, alongside first quarter earnings showing higher revenue and a continued net loss. See our latest analysis for Globalstar. Globalstar’s 1 month share price return of 13.0% and 3 month share price return of 41.0% have coincided with the Falcon 9 launch news and the latest earnings update. Meanwhile, the 1...
NYSE:FIG
NYSE:FIGSoftware

Assessing Figma (FIG) Valuation After Recent Share Price Pressure And Conflicting Fair Value Signals

Figma stock overview after recent trading moves Figma (FIG) shares have been under pressure recently, with the stock down around 4% over the past day and slightly lower over the past week, even as the month performance remains positive. See our latest analysis for Figma. Recent trading fits a wider pattern for Figma, with the 1 month share price return still up 6.44% but the year to date share price return down 48.60%. This suggests that momentum has been fading after an earlier rebound. If...
NYSE:GNRC
NYSE:GNRCElectrical

A Look At Generac Holdings (GNRC) Valuation After Strong Recent Share Price Gains

Stock performance snapshot and recent returns Generac Holdings (GNRC) has drawn fresh investor attention after a strong recent run in the stock, with the share price closing at US$269.59 and sizeable gains over the past month and past 3 months. Over the past month, the stock is up about 30%, with a gain of roughly 25% over the past 3 months and a year to date return close to 91%. The 1 year total return is around 109%, while the 3 year total return is very large at roughly 14x, set against a...
NYSE:PRI
NYSE:PRIInsurance

Primerica (PRI) Valuation Check After Q1 Growth And Dividend Affirmation

Primerica’s latest earnings and dividend decision Primerica (PRI) reported first quarter 2026 results with revenue of US$872.69 million and net income of US$190.1 million, alongside an affirmed quarterly dividend of US$1.20 per share. See our latest analysis for Primerica. Primerica’s latest earnings and dividend news comes as the stock trades at US$273.77, with a 90-day share price return of 8.02% and a 5-year total shareholder return of 84.73%, suggesting momentum has built over time,...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Broadcom Weighs Record US$35b AI Credit Deal And Investor Tradeoffs

Broadcom (NasdaqGS:AVGO) is reportedly in talks for a record US$35b private credit deal to fund its custom AI chip expansion. The financing would support multi-year hardware supply agreements with major AI customers, including Google and Anthropic. The potential transaction is described as the largest private credit deal to date, focused on datacenter AI infrastructure. For you as an investor, this points to how central custom AI chips have become to Broadcom's story. The company already...
OTCPK:FTCO
OTCPK:FTCOMetals and Mining

Fortitude Gold Q1 2026 Loss And Revenue Compression Reinforce Bearish Narratives

Fortitude Gold Q1 2026 earnings snapshot Fortitude Gold (FTCO) opened Q1 2026 with trailing 12 month revenue of US$18.4 million and basic EPS of US$0.017, while the latest reported quarter, Q4 2025, showed quarterly revenue of US$2.3 million and a basic EPS loss of US$0.078 as margins compressed. Over recent quarters, the company has seen revenue move from US$9.37 million in Q4 2024 to US$6.54 million in Q1 2025 and then to US$4.88 million in Q2 2025, with basic EPS shifting from a loss of...
NYSE:MA
NYSE:MADiversified Financial

Mastercard Taps CAF Partnership To Grow Inclusive Latin America MSME Credit

Mastercard (NYSE:MA) has partnered with CAF, the Development Bank of Latin America and the Caribbean, to expand access to credit for MSMEs across the region. The collaboration focuses on underserved communities, women led businesses, and projects with climate impact objectives. The initiative targets micro, small and medium enterprises across Latin America and the Caribbean, aiming to improve financial inclusion and support sustainable development. For investors tracking Mastercard at a...
NYSE:ABT
NYSE:ABTMedical Equipment

Abbott Securities Lawsuit Deepens Infant Formula Risks For Shareholders

Abbott Laboratories is facing a securities class action lawsuit alleging it concealed FDA health and safety violations at its infant formula facility. The case follows a recently upheld $495 million verdict related to Abbott's baby formula operations and extends legal exposure to shareholders. Investors are watching for potential regulatory actions such as recalls or plant closures and any resulting impact on Abbott's financial position. For investors in Abbott Laboratories (NYSE:ABT), this...
NYSE:EW
NYSE:EWMedical Equipment

Is Edwards’ RESILIA Trial Success And New CFO Appointment Altering The Investment Case For EW?

Earlier this month, Edwards Lifesciences reported 10-year COMMENCE aortic trial results showing durable performance of its RESILIA tissue valves, and named Theodora (“Doretta”) Mistras, formerly Viatris CFO and a long-time healthcare investment banker, as its new chief financial officer, effective at the end of May. Together, the reinforced clinical evidence for RESILIA technology and the appointment of a financially seasoned healthcare leader could be important for how investors view...
NasdaqGS:MXL
NasdaqGS:MXLSemiconductor

A Look At MaxLinear (MXL) Valuation After Strong Q1 Earnings And New AI Data Center Products

MaxLinear (MXL) has quickly moved back onto investor radar after strong Q1 results, a swing to positive adjusted earnings, and higher Q2 sales guidance supported by new AI focused data center products. See our latest analysis for MaxLinear. Those stronger Q1 numbers and new AI data center products have been reflected in the share price, with a 30 day share price return of 344.32% and a 90 day share price return of 373.87%. The 1 year total shareholder return is also very large, pointing to...
NasdaqGS:SATS
NasdaqGS:SATSMedia

EchoStar (SATS) Q1 Loss Shrink Challenges Bearish Narratives On Deep Trailing Losses

EchoStar’s latest numbers set the stage for a changing profitability story EchoStar (SATS) opened 2026 with Q1 revenue of US$3.7b and a basic EPS loss of US$0.51, alongside a trailing twelve month EPS loss of US$50.11 that highlights how deep the recent earnings pressure has been. Over the past five quarters, revenue has moved between US$3.6b and US$4.0b while quarterly basic EPS has swung from a profit of US$1.19 in Q4 2024 to losses of US$0.51 to US$44.37 through 2025, setting a wide...
NasdaqGS:PDFS
NasdaqGS:PDFSSemiconductor

Assessing PDF Solutions (PDFS) Valuation After Strong Recent Share Price Momentum

Stock performance context PDF Solutions (PDFS) has drawn investor attention after a recent share price move, with the stock closing at US$50.95 and posting returns over the past month and past 3 months that outpaced its shorter term performance. For context, the stock is up 31.2% over the past month and 56.7% over the past 3 months, alongside a 1 year total return of 162.5% and a market value of about US$2.2b. See our latest analysis for PDF Solutions. The recent move to US$50.95 comes after...
NasdaqGS:FCNC.A
NasdaqGS:FCNC.ABanks

A Look At First Citizens BancShares (FCNC.A) Valuation After Recent Share Price Weakness

Why First Citizens BancShares (FCNC.A) is on investor watchlists First Citizens BancShares (FCNC.A) has drawn fresh attention after its share price declined 4.1% over the past month and 4.2% over the past 3 months, prompting investors to reassess the bank’s recent performance. Over the past year, the stock is down 1.8%, while the year to date move shows an 11.1% decline. In this context, investors are weighing the company’s fundamentals, valuation metrics and long term track record. See our...